LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PBC FROM THE POISE TRIAL GROUPED BIOCHEMICALLY BY RISK OF DISEASE PROGRESSION
Bowlus CL, Trauner MH, Kremer A, Liberman A, Malecha ES, Macconell L, Nevens F (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: WILEY
City/Town: HOBOKEN
Pages Range: 751A-752A
Conference Proceedings Title: HEPATOLOGY
DOI: 10.1016/j.dld.2020.12.049
Authors with CRIS profile
Involved external institutions
University of California Davis (UCDAVIS)
United States (USA) (US)
Medizinische Universität Wien
Austria (AT)
Intercept Pharmaceuticals
United States (USA) (US)
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
Belgium (BE)
United States (USA) (US)
Medizinische Universität Wien
Austria (AT)
Intercept Pharmaceuticals
United States (USA) (US)
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
Belgium (BE)
How to cite
APA:
Bowlus, C.L., Trauner, M.H., Kremer, A., Liberman, A., Malecha, E.S., Macconell, L., & Nevens, F. (2020). LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PBC FROM THE POISE TRIAL GROUPED BIOCHEMICALLY BY RISK OF DISEASE PROGRESSION. In HEPATOLOGY (pp. 751A-752A). HOBOKEN: WILEY.
MLA:
Bowlus, Christopher L., et al. "LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PBC FROM THE POISE TRIAL GROUPED BIOCHEMICALLY BY RISK OF DISEASE PROGRESSION." Proceedings of the Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) HOBOKEN: WILEY, 2020. 751A-752A.
BibTeX: Download